Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CASTLEVAX INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-09-30 to 2027-08-02
Current total value of award: $8398919
Description: DEVELOP A NEXT-GENERATION, MUCOSALLY DELIVERED, COVID-19 BOOSTER VACCINE CAPABLE OF ELICITING MUCOSAL IMMUNITY AND PROTECTING AGAINST SARS-COV-2 BREAKTHROUGH INFECTION AND TRANSMISSION